Market Research Logo

European Market Report for Central Venous Catheters 2017 - MedCore

European Market Report for Central Venous Catheters 2017 - MedCore

The European CVC market includes acute and chronic CVCs. Acute CVCs are classified as either conventional acute CVCs or antimicrobial acute CVCs. The acute CVC market includes conventional and antimicrobial acute CVCs. The acute CVC market is expected to grow only slightly over the forecast period, driven primarily by increases in the size and age of the European patient pool and the continued reliance on CVCs. The acute CVC market is growing mainly due to the increasing use of antimicrobial CVCs for high-risk patients. These devices sell at a slight premium to conventional devices and the conversion to antimicrobial CVCs will lead to a growth in market value. The introduction of antithrombogenic CVCs has had a positive effect on the market.

Central venous catheters (CVCs) are used for gaining immediate, high-flow vascular access. CVCs are inserted via the large internal jugular, subclavian and femoral veins. The larger diameter of central veins compared with peripheral veins allows CVCs to have higher potential flow rates and accommodate more lumens. CVCs are commonly used for parenteral nutrition, blood transfusions, blood draws and medication and chemotherapy delivery. CVCs have long been the standard device used for gaining vascular access in emergency situations where patients require large volumes of fluids in short periods of time. CVCs have long been the standard device used to gain vascular access.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Human Vascular System
2.2 VASCULAR PATHOLOGY AND DISORDERS
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Central Venous Catheters
3.1.1.1 Introduction
3.1.1.1.1 CVC Procedures
3.1.1.1.2 CVC Kits
3.1.1.1.3 CVC Market Segments
3.1.1.2 AngioDynamics
3.1.1.2.1 NeoStar™
3.1.1.3 Centurion Medical Products
3.1.1.3.1 Vantex™
3.1.1.3.2 Multi-Med™
3.1.1.3.3 AVA™
3.1.1.4 Cook Medical
3.1.1.4.1 Spectrum®
3.1.1.5 C.R. Bard
3.1.1.5.1 PowerHohn®
3.1.1.5.2 Hohn®
3.1.1.5.3 Other CVC Offerings
3.1.1.6 Medcomp Inc.
3.1.1.6.1 Pro-Line®
3.1.1.6.2 Vascu-Line®
3.1.1.6.3 Other CVC Offerings
3.1.1.7 Teleflex Medical
3.1.1.7.1 Standard
3.1.1.7.2 ARROWg+ard Blue®
3.1.1.7.3 ARROWg+ard Blue Plus®
3.1.1.7.4 Chlorag+ard®
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 CLINICAL TRIALS
3.3.1 Central Venous Catheters
3.4 PRODUCT PIPELINES
3.4.1 Alliance Vascular Devices, LLC
3.4.1.1 FreeHand Safety Huber Needle®
3.4.2 AngioDynamics
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation
3.4.2.2 Firefly
3.4.2.3 BioFlo® PICC Line Extension
3.4.2.4 BioFlo® Port Line Extension
3.4.2.5 Next Generation BioFlo® PICC
3.4.2.6 Next Generation BioFlo® Port
3.4.3 Bluegrass Vascular Technologies, Inc.
3.4.3.1 Surfacer® Inside-Out™ Access System
3.4.4 C.R. Bard
3.4.4.1 Chemical-Resistant PICCs
3.4.4.2 Novel Advanced Material PICCs
3.4.4.3 PowerGlide® Pro Midline
3.4.4.4 AccuCath®
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter
3.4.4.6 Site~Rite® 8 Ultrasound System
3.4.5 M. C. Johnson
3.4.5.1 PICC Securement Device
3.4.6 Nipro Medical
3.4.6.1 Shielding Safety Needle
3.4.6.2 Safety Syringe
3.4.6.3 Safety PIVC
3.4.7 Parasol Medical
3.4.7.1 Catheter Securement Device
3.4.8 PAVmed Inc.
3.4.8.1 NextCath™
3.4.9 Phase One Medical
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter
3.4.10 Prodigy Diabetes Care, LLC.
3.4.10.1 Insulin Pen Needles
3.4.11 Sharklet Technologies, Inc.
3.4.11.1 Sharklet™ Central Venous Catheter
3.4.12 Starboard Medical
3.4.12.1 Catheter Securement Devices
3.4.13 Teleflex Medical
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
3.4.14 Vascular Access Technologies, Inc.
3.4.14.1 SAFECVAD™
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP Per Capita
4.1.3 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
CENTRAL VENOUS CATHETER MARKET
5.1 INTRODUCTION
5.1.1 CVC Procedures
5.1.2 CVC Kits
5.1.3 CVC Market Segments
5.1.4 Antimicrobial CVCs
5.1.5 Multi-Lumen CVCs
5.1.6 Chronic CVCs
5.2 UNIT ANALYSIS
5.2.1.1 Acute CVC Units Sold by Patient Type
5.3 MARKET OVERVIEW
5.4 MARKET ANALYSIS AND FORECAST
5.4.1 Total Central Venous Catheter Market
5.4.2 Total Acute Central Venous Catheter Market
5.4.2.1 Conventional Acute Central Venous Catheter Market
5.4.2.2 Antimicrobial Acute Central Venous Catheter Market
5.4.3 Chronic Central Venous Catheter Market
5.5 DRIVERS AND LIMITERS
5.5.1 Market Drivers
5.5.2 Market Limiters
5.6 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023
Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
Chart 3 1: Central Venous Catheter Market Segments, 2015
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
Chart 5 1: Central Venous Catheter Market by Segment, Europe, 2013 – 2023
Chart 5 2: Central Venous Catheter Market Breakdown, Europe, 2016
Chart 5 3: Central Venous Catheter Market Breakdown, Europe, 2023
Chart 5 4: Total Central Venous Catheter Market, Europe, 2013 – 2023
Chart 5 5: Total Acute Central Venous Catheter Market, Europe, 2013 – 2023
Chart 5 6: Chronic Central Venous Catheter Market, Europe, 2013 – 2023
Chart 5 7: Leading Competitors, Total Central Venous Catheter Market, Europe, 2016
List of Figures
Figure 1 1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2)
Figure 1 2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2016
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013 – 2016
Figure 1 6: Vascular Access Procedures Covered, Europe, 2016
Figure 1 7: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (1 of 3)
Figure 1 8: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (2 of 3)
Figure 1 9: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (3 of 3)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Class 2 Device Recall Medtronic
Figure 3 2: Class 2 Device Recall Smiths Medical
Figure 3 3: Class 2 Device Recall Arrow
Figure 3 4: Class 2 Device Recall Arrow
Figure 3 5: Class 2 Device Recall Covidien (Medtronic)
Figure 3 6: Class 2 Device Recall Arrow
Figure 3 7: Class 2 Device Recall Medline
Figure 3 8: Class 2 Device Recall Arrow
Figure 3 9: Class 2 Device Recall B. Braun
Figure 3 10: Class 3 Device Recall Bard Access
Figure 3 11: Class 2 Device Recall Covidien (Medtronic)
Figure 3 12: Class 2 Device Recall Bard Access
Figure 3 13: Class 2 Device Recall Bard Access
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics
Figure 3 15: Class 2 Device Recall Bard Access
Figure 3 16: Class 2 Device Recall Arrow
Figure 3 17: Class 2 Device Recall Medcomp
Figure 3 18: Class 2 Device Recall Arrow
Figure 3 19: Class 2 Device Recall Arrow
Figure 3 20: Class 2 Device Recall Smiths Medical
Figure 3 21: Class 2 Device Recall PFM Medical
Figure 3 22: Class 2 Device Recall PFM Medical
Figure 3 23: Class 2 Device Recall Becton Dickinson
Figure 3 24: Class 2 Device Recall Arrow
Figure 3 25: Class 2 Device Recall Arrow
Figure 3 26: Class 2 Device Recall Navilyst Medical
Figure 3 27: Class 2 Device Recall Argon Medical
Figure 3 28: Class 2 Device Recall Arrow
Figure 3 29: Class 2 Device Recall Arrow
Figure 3 30: Class 2 Device Recall Arrow
Figure 3 31: Class 2 Device Recall Bard Access
Figure 3 32: Class 2 Device Recall Navilyst Medical
Figure 3 33: Class 2 Device Recall Bard Access
Figure 3 34: Class 2 Device Recall Smiths Medical
Figure 3 35: Class 2 Device Recall B. Braun
Figure 3 36: Class 2 Device Recall Smiths Medical
Figure 3 37: Class 2 Device Recall Access Scientific
Figure 3 38: Class 2 Device Recall Covidien (Medtronic)
Figure 3 39: Class 2 Device Recall Arrow
Figure 3 40: Class 2 Device Recall Bard Access
Figure 3 41: Class 2 Device Recall Becton Dickinson
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 43: Class 2 Device Recall Bard Access
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 45: Class 2 Device Recall Medcomp
Figure 3 46: Class 2 Device Recall Becton Dickinson
Figure 3 47: Class 3 Device Recall Bard Access
Figure 3 48: Class 2 Device Recall Medcomp
Figure 3 49: Class 1 Device Recall Arrow
Figure 3 50: Class 2 Device Recall Arrow
Figure 3 51: Class 2 Device Recall Vygon
Figure 3 52: Class 2 Device Recall Covidien (Medtronic)
Figure 3 53: Class 2 Device Recall Medcomp
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 55: Class 2 Device Recall Christie Medical Holdings
Figure 3 56: Class 3 Recall Bard Access
Figure 3 57: Class 2 Device Recall AngioDynamics
Figure 3 58: Class 2 Device Recall Becton Dickinson
Figure 3 59: Class 2 Device Recall AngioDynamics
Figure 3 60: Class 2 Device Recall AngioDynamics
Figure 3 61: Class 3 Device Recall AngioDynamics
Figure 3 62: Class 2 Device Recall AngioDynamics
Figure 3 63: Central Line Placement Study
Figure 3 64: The Effects of Anti-infective Central Venous Catheter (CVC)
Figure 3 65: The Use of Point of Care Ultra Sound
Figure 3 66: Complications Associated With Central Venous Access
Figure 3 67: Impact of Ultrasound Guided Central Venous Catheterization
Figure 3 68: Randomized, Prospective, Single-center Study
Figure 3 69: Remifentanil and Local Anesthesia
Figure 3 70: Dissemination of a Simulation-based Mastery Learning Curriculum
Figure 3 71: Incidence of Complication
Figure 3 72: Comparison of Two Needle Insertion Techniques
Figure 3 73: A Monocenter Prospective Study
Figure 3 74: A Prospective Study to Compare Point of Care Echocardiography Versus Chest Radiography
Figure 3 75: Long-versus Short-Axis Ultrasound Guidance for Subclavian Vein Cannulation
Figure 3 76: Use of Chlorhexidine-gel-Impregnated Dressing Compared to Transparent Polyurethane Film Dressing
Figure 3 77: Vascular Access in Hematological Patients
Figure 3 78: Developing and Maintaining a Central Venous Catheter Registry
Figure 3 79: Reliability of Central Venous Pressure Measurements
Figure 3 80: SUBclavian Central Venous Catheters Guidance and Examination by UltraSound
Figure 3 81: Chlorhexidine Containing IV-securement Dressings
Figure 3 82: Comparison of Effectiveness and Safety of Two Methods for Installing Femoral Central Venous Catheters
Figure 3 83: A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters
Figure 3 84: Ultrasound Guided Diagnosis of Central Venous Catheters in Children
Figure 3 85: Real-time Ultrasound-guided Catheterization of the Axillary Vein in the Intensive Care Unit
Figure 3 86: Determination of Anatomic Variations of the Internal Jugular and Femoral Veins
Figure 3 87: Comparison of Subclavian, Femoral and Internal Jugular Venous Catheterization
Figure 3 88: Landmark vs. Ultrasound Guided Subclavian Central Venous Catheter Placement
Figure 3 89: Interest of Ultrasound Coupled to a Guidance System (GPS)
Figure 3 90: Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement
Figure 3 91: Comparison of the Central Venous Catheter Insertion Techniques
Figure 3 92: A Multicenter, Open-label, Randomised, Clinical Trial
Figure 5 1: Acute CVC Units Sold by Patient Type, Europe, 2016
Figure 5 2: Central Venous Catheter Market by Segment, Europe, 2013 – 2023 (€M)
Figure 5 3: Central Venous Catheter Market by Segment, Europe, 2013 – 2023 (US$M)
Figure 5 4: Total Central Venous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 5: Units Sold by Country, Total Central Venous Catheter Market, Europe, 2013 – 2023
Figure 5 6: Average Selling Price by Country, Total Central Venous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 7: Average Selling Price by Country, Total Central Venous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 8: Market Value by Country, Total Central Venous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 9: Market Value by Country, Total Central Venous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 10: Total Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 11: Units Sold by Country, Total Acute Central Venous Catheter Market, Europe, 2013 – 2023
Figure 5 12: Average Selling Price by Country, Total Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 13: Average Selling Price by Country, Total Acute Central Venous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 14: Market Value by Country, Total Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 15: Market Value by Country, Total Acute Central Venous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 16: Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 17: Units Sold by Country, Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023
Figure 5 18: Average Selling Price by Country, Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 19: Average Selling Price by Country, Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 20: Market Value by Country, Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 21: Market Value by Country, Conventional Acute Central Venous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 22: Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 23: Units Sold by Country, Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023
Figure 5 24: Average Selling Price by Country, Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 25: Average Selling Price by Country, Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 26: Market Value by Country, Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 27: Market Value by Country, Antimicrobial Acute Central Venous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 28: Chronic Central Venous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 29: Units Sold by Country, Chronic Central Venous Catheter Market, Europe, 2013 – 2023
Figure 5 30: Average Selling Price by Country, Chronic Central Venous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 31: Average Selling Price by Country, Chronic Central Venous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 32: Market Value by Country, Chronic Central Venous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 33: Market Value by Country, Chronic Central Venous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 34: Drivers and Limiters, Central Venous Catheter Market, Europe, 2016
Figure 5 35: Leading Competitors by Country, Total Central Venous Catheter Market, Europe, 2016
Figure 5 36: Leading Competitors by Country, Acute Central Venous Catheter Market, Europe, 2016
Figure 5 37: Leading Competitors by Country, Chronic Central Venous Catheter Market, Europe, 2016
Figure 7 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report